Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Randomized Trial of Low-dose Naltrexone for Post-COVID Fatigue Syndrome

NCT05430152 is registered in ClinicalTrials.gov with Luis Nacul as lead sponsor.

NCT NCT05430152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05430152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Randomized Trial of Low-dose Naltrexone for Post-COVID Fatigue Syndrome
Lead sponsor
Luis Nacul
Phase
Phase 2
Overall status
Completed
Start date
January 15, 2024
Completion date
February 28, 2026
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-viral fatigue syndrome